BIOMARKER:

AR mutation

Entrez ID:

Related biomarkers:

‹

›

AR mutation AR mutation	Prostate Cancer Prostate Cancer	AR mutation AR mutation	Prostate Cancer Prostate Cancer	PCM-075 Sensitive: C3 – Early Trials	PCM-075 Sensitive: C3 – Early Trials
AR mutation AR mutation	Prostate Cancer Prostate Cancer	AR mutation AR mutation	Prostate Cancer Prostate Cancer	abiraterone acetate + GDC-0068 Resistant: C3 – Early Trials	abiraterone acetate + GDC-0068 Resistant: C3 – Early Trials
AR mutation AR mutation	Prostate Cancer Prostate Cancer	AR mutation AR mutation	Prostate Cancer Prostate Cancer	enzalutamide Resistant: C3 – Early Trials	enzalutamide Resistant: C3 – Early Trials
AR mutation AR mutation	Prostate Cancer Prostate Cancer	AR mutation AR mutation	Prostate Cancer Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials	abiraterone acetate Resistant: C3 – Early Trials
AR mutation AR mutation	Prostate Cancer Prostate Cancer	AR mutation AR mutation	Prostate Cancer Prostate Cancer	CPI-0209 Sensitive: D – Preclinical	CPI-0209 Sensitive: D – Preclinical